Quantitative Pathology: Historical Background, Clinical Research and Application of Nuclear Morphometry and DNA Image Cytometry

References

• Muller J. On the nature and structural characteristics of cancer and morbid growth which may be confounded with it. Translated by Charles West. London, Shrewood, Gilbert and Piper, 1840
   Google Scholar
• Donne A. Cours de microscopie complémentaire des etudes médicales:Anatomie microscopique et physiologie des fluides de l’Economie:Atlas execute d’Apres nature au microscope daguerreotype. Paris, BaIlière, 1845.
   Google Scholar
• Hansemann D. von. Ober asymmetrische Zellteilung in Epithel-Krebsen und deren biologische Bedeutung. Arch Pathol Anat Physiol 1890; 199:299–327
   Google Scholar
• Sterobe H. Zur Kenntnis Verschiedener Zellularvorgange und Erscheinungen in Geschwulsten. Beitr Pathol Ant 1892; 11:1–38
   Google Scholar
• Boveri TC. Zur Frage der Entstehung von malignen Tumouren. Fischer, Jena 1914
   Google Scholar
• Haumeder E. Vergleichende Kernund Nukleolenmessungen an verschiedenen Organen und Geweben mit besonderer Berüksichtigung der malignen Tumourzellen. Z Krebs Forsch 1933; 40:105–116
   Google Scholar
• FeuIgen F, Rossen beck H. Mikrosko-pisch-chemischer Nachweis einer Nukleinsaure vom Typus der Thymonuke-insaure preparaten. Hoppe-Seylers Z Phys Chem 1924; 135:203–248
   Google Scholar
• Jacobi W. Ober das rhythmische Wachstum der Zellen durch Verdoppelung ihres Volumens. Arch Entwickl Mech Org 1925; 106:124–192
   PubMedGoogle Scholar
• Heiberg KH and Kemp T. Ober die Zahl der chromosomen in Karzinomzellen beim Menschen. Virchows Arch (Pathol Anat) 1929; 273:693–700
   Google Scholar
• Koss LG. Analytical and quantitative cytology. A historical perspective. Anal Quant Cytol 1982; 4:251–256
   Google Scholar
• Koss LG. Automated cytology and histology, A historical perspective. Anal Quant Cytol Histol 1987; 9:369–374
   PubMedGoogle Scholar
• Caspersson TO. History of the development of cytophotometry from 1935 to the present. Anal Quant Cytol Histol 1987; 9:2–6
   Google Scholar
• Baak JP. Manual of quantitative pathology in cancer diagnosis and prognosis. Springer Verlage Berlin Heidel-berg 1991;3–6.
   Google Scholar
• Mariuzzi GM, Collan YU. Some reflections on the history, and presence of quantitative pathology. Pathologica 1995; 87:215–220
   Google Scholar
• Brawer Mk: Prostate intraepithelial neoplasia:A premalignant condition. Hum Pathol 1992; 23:242–248
   PubMed Web of Science ®Google Scholar
• Malinin Ti, Hornicek FJ, Block NL, Malinin GI: Aneuploidy of glandular epithelial cells in histologically normal prostate glands. Experientia 1988; 44:247–249
   Google Scholar
• Merkel DE, McGuire WL: Ploidy, proliferative ctivity and prognosis:DNA flow cytometry of solid tumours. Cancer 1990; 65:1194–1205
   PubMed Web of Science ®Google Scholar
• William NN, Daly JM: Cytometry and prognostic implications in patients with solid tumours. Surg Gynecol Obstet 1990; 171:257–266
   Google Scholar
• Pindur A, Chakraborty S, Welch D G, Wheeler TM. DNA ploidy measurements in prostate cancer:differences between image analysis and flow cytometry and clinical implications. Pros-tate 1994; 25:189–198
   PubMed Web of Science ®Google Scholar
• Falkmer UG. Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma. Hum Pathol 1992; 23:360–367
   PubMed Web of Science ®Google Scholar
• Hardt NS, Hendricks JB, Sapi Z, Tykochinsky G, Wilkinson EJ, Epstein HB, Wajsman Z. Ploidy results in prostatic carcinoma vary with sampling method and with cytometric technique. Mod Pathol 1994; 7:44–48
   Web of Science ®Google Scholar
• Hiddemann W, Schumann J, An-dreef M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA. Convention on nomenclature for DNA cytometry. Committee on Nomen-clature, Society for Analytical Cytology. Cancer Genet Cytogenet 1984; 13:181–183
   PubMedGoogle Scholar
• Backing A, Auffermann W, Schwarz H, Bammert J, Dorrier G, Vacicujas S. Cytology of prostatic carcinoma:Quantitation and validation of diagnostic criteria Anal Quant Cytol Histol 1984; 6:77–88
   Google Scholar
• Chatelain R, Schunck T, Schindler EM, Schindler AE, Backing A. Diagno-sis of prospective malignancy in koilocytic dysplasias of the cervix with DNA cytometry. J Reprod Med 1989; 34:505–510
   Web of Science ®Google Scholar
• Kropff M, Chatelain R, Muller CP, Wagner A, Wenzler T, Bohmer H, Backing A. Monitoring DNA cytometric parameters during the course of chronic myelogenous leukemia. Anal Quant Cytol Histol 1991; 13:433–439
   Google Scholar
• Backing A, Auffermann W. Algo-rithm for DNA cytophotometric diagnosis and grading of malignancy. Anal Quant Cytol Histol 1986;8:363
   Google Scholar
• Opfermann M, Brugal G, Vassila-kos P. Cytometry of breast carcinoma:significance of ploidy balance and proliferation index. Cytometry 1987; 8:217–224
   Google Scholar
• Tribukait B, Ronstrom L, Esposti PL. Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostatic carcinoma. Anal Quant Cytol 1983; 5:107–111
   PubMedGoogle Scholar
• Albe X, Vassilakos P, Helfer Guar-noni K, Givel JC, de Quay N, Suardet L, Eliason JF, Odartchenko N. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry. Cancer 1990; 66:1168–1175
   PubMed Web of Science ®Google Scholar
• Forsslund G, Zetterberg A. Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 1990; 50:4281–4285
   PubMed Web of Science ®Google Scholar
• Tribukait B:Nuclear deoxyribonucleic acid determination in patients with prostate carcinomas:clinical research and application. Eur Urol 1993;23 Supp1 2:64–76
   Google Scholar
• ROnstrOm L, Tribukait B, Esposti PL: DNA pattern and cytological findings in fine needle aspirates of untreated prostatic tumoursx. A flow cytofluorometric study. Prostate 1981; 2:79–88
   PubMed Web of Science ®Google Scholar
• Adolfsson J, Tribukait B: Evaluation of tumour progression by repeated fine needle biopsies in prostate adenocar-cinoma:modal deoxyribonucleic acid value and cytological differentiation. J Urol 1990; 144:1408–1410
   PubMed Web of Science ®Google Scholar
• Auer GU, Caspersson TO, Wallgran AS: DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980; 2:161–165
   PubMedGoogle Scholar
• Buhmeida A, CoIlan Y: Fine needle aspiration biopsies of the prostate:Evidence of DNA cytometric abnormalities in cytologically benign lesions. Elec-tronic Journal of Pathology and Histol-ogy 2001;7 (4):1–11
   Google Scholar
• Zinke H, Larson Keller JJ. Stage D1 prostate cancer treated by RP and adjuvant hormonal treatment. Cancer 1992,:311–323
   Google Scholar
• Tavares AS, Costa J, Carvalho A, Reis M. Tumour ploidy and prognosis in carcinomas of the bladder and pros-tate. Br J Cancer 1966, 20:438–441.
   Web of Science ®Google Scholar
• Epstein JI, Christensen WN, Stein-berg GD, Carter HB. Comparison of DNA ploidy and nuclear size, shape and chromatin irregularity in tissue sections and smears of prostatic carcinoma. Anal Quant Cytol Histol 1990, 12:352–358.
   PubMed Web of Science ®Google Scholar
• Forsslund G, Esposti PL, Nilsson B, Zetterberg A. The prognostic significance of nuclear DNA content in prostatic carcinoma. Cancer 1992, 69:1432–1439.
   PubMed Web of Science ®Google Scholar
• Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM. Relationship between DNA ploidy, glandular differentiation, and tumour spread in human prostate cancer. Cancer Res 1985, 45:1418–1423.
   PubMed Web of Science ®Google Scholar
• Forsslund G, Zetterberg A. Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 1990, 50:4281–4285.
   PubMed Web of Science ®Google Scholar
• Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing:15-year outcome. BJU Int 2005, 95:751–756.
   PubMed Web of Science ®Google Scholar
• Galizia G, Orditura M, Romano C et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002; 102 (2):169–78.
   PubMed Web of Science ®Google Scholar
• Bazan V, Migliavacca M, Zanna I et al. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. Cancer Res Clin Oncol 2002; 128 (12):650–8.
   Web of Science ®Google Scholar
• Cohen C. Image cytometric analysis in pathology. Hum Pathol 1996; 27 (5):482–93.
   Web of Science ®Google Scholar
• Millot C, Dufer J. Clinical applications of image cytometry to human tumour analysis. Histol Histopathol 2000; 15 (4):1185–200.
   Web of Science ®Google Scholar
• Scott NA, Wieand HS, Moertel CG et al. Colorectal cancer. Dukes’ stage, tumour site, preoperative plasma CEA level, and patient prognosis related to tumour DNA ploidy pattern. Arch Surg 1987; 122 (12):1375–9.
   Google Scholar
• Witzig TE, Loprinzi CL, Gonchoroff NJ et al. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 1991; 15; 68 (4):879–88.
   Google Scholar
• Lanza G, Gafa R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L. Prognostic significance of DNA ploidy in patients with stage II and stage ill colon carcinoma:a prospective flow cytometric study. Cancer. 1998 1; 82 (1):49–59.
   Web of Science ®Google Scholar
• Zarbo RJ, Nakhleh RE, Brown RD et al. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Cancer 1997; 79 (11):2073–86.
   Web of Science ®Google Scholar
• Tonouchi H, Matsumoto K, Kinoshita T et al. Prognostic value of DNA ploidy patterns of colorectal adeno-carcinoma:univariate and multivariate analysis. Dig Surg 1998; 15 (6):687–92.
   Web of Science ®Google Scholar
• Petersen SE, Bichel P, Lorentzen M. Flow-cytometric demonstration of tumour-cell subpopulations with different DNA content in human cobrectal carcinoma. Eur J Cancer 1979; 15 (4):383–6
   Web of Science ®Google Scholar
• Tribukait B, Hammarberg C, Rubio C. Ploidy and proliferation patterns in cobrectal adenocarcinomas related to Dukes’ classification and to histopatho-logical differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand 1983; 91 (2):89–95
   Google Scholar
• Rajagopalan H, Lengauer C. hCDC4 and genetic instability in cancer. Cell Cycle 2004; 3 (6):693–4.
   Web of Science ®Google Scholar
• Jaffrey RG, Pritchard SC, Clark C et al. Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer. Cancer Res 2002; 15; 60 (16):4349–52.
   Web of Science ®Google Scholar
• Giaretti W, Molinu S, Ceccarelli J et al. Chromosomal instability, aneuploidy, and gene mutations in human sporadic colorectal adenomas. Cell Oncol 2004; 26 (5-6):301–5.
   Web of Science ®Google Scholar
• Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4NOMO colorectal cancer. Hepatogastroenterology. 2004; 51 (60):1689–93.
   PubMedGoogle Scholar
• Roman S, Cenni JC, Roy P, Pujol B, Napoleon B, Keriven-Souquet O, Souquet JC. Value of rectal ultrasound in predicting staging and outcome in patients with rectal adenocarcinoma. Dis Colon Rectum. 2004; 47 (8):1323–30.
   Web of Science ®Google Scholar
• Phillips R.S.K, Hittinger R. and Blesovsky L. Large bowel cancer:surgical pathology and its relationship to survival. Br J Surg 71 (1984), pp. 604–610
   PubMed Web of Science ®Google Scholar
• Chapuis PH, Deut OF. and Fisher R. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72 (1985) , pp. 698–702.
   Web of Science ®Google Scholar
• Wiggers T., Arends J.W., Schutte B. et al. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 61 (1988) , pp. 386–395
   Web of Science ®Google Scholar
• Sokmen S, Sarioglu S, Fuzun M, Terzi C, Kupelioglu A, Asian B. Prognostic significance of angiogenesis in rectal cancer:a morphometric investigation. Anticancer Res. 2001;21 (6B):4341–8
   Web of Science ®Google Scholar
• Deans G.T., Hamilton P.W., Watt P.C.H. et al. Morphometric analysis of colorectal cancer. Dis Colon Rectum 36 (1993) , pp. 450–456
   Web of Science ®Google Scholar
• Dundas S.A., Laing R.W. O’Cathain A. Feasibility of new prognostic classification for rectal cancer. J Clin Pathol 41 (1988), pp. 1273–1276
   PubMed Web of Science ®Google Scholar
• Zhang YH, Kanamaru H, Oyama N, Miwa Y, Suzuki Y, Akino H, Noriki S, Okada K. Prognostic value of nuclear morphometry on needle biopsy from patients with prostate cancer:is volume-weighted mean nuclear volume superior to other morphometric param-eters? Urology 2000 ; 55 (3):377–81.
   Web of Science ®Google Scholar
• Jalava P, Kronqvist P, Smrzova B, Juntti-Patinen L, Kuopio T, CoIlan YU. Nuclear volume and breast cancer prognosis. Anticancer Res 2001 ; 21 (16):727–32.
   Google Scholar
• Mitmaker, B., Begin, L.R., Gordon, P.H. Nuclear shape as a prognostic discriminant in colorectal carcinoma. Dis Colon Rectum 1991;34 (3):249–259.
   Web of Science ®Google Scholar
• Buhmeida A, Kuopio T, CoIlan Y. Nuclear size and shape in fine needle aspiration biopsy samples of the prostate. Anal Quant Cytol Histol. 2000; 22 (4):291–8
   PubMedGoogle Scholar
• Kazanowska B, Jelen M, Reich A, Tarnawski W, Chybicka A. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children. Histopathology. 2004; 45 (4):352–9
   Web of Science ®Google Scholar
• Diamond DA, Berry SJ, Umbricht C, Jewett HJ, Coffey DS. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer. Prostate 1982a, 3 (4):321–32.
   Web of Science ®Google Scholar
• Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS. A new method to assess metastatic potential of human prostate cancer:relative nuclear roundness. J Urol 1982b, 128:729–734.
   Web of Science ®Google Scholar
• Epstein JI, Berry SJ, Eggleston JC. Nuclear roundness factor. A predictor of progression in untreated stage A2 prostate cancer. Cancer 1984, 54:666–671.
   Web of Science ®Google Scholar
• Clark TD, Askin FB, Bagnell CR. Nuclear roundness factor:a quantitative approach to grading in prostatic carcinoma, reliability of needle biopsy tissue, and the effect of tumour stage on usefulness. Prostate 1987, 10:199–206.
   PubMed Web of Science ®Google Scholar
• Eichenberger T, Mihatsch MJ, Ober-holzer M, Gschwind R, Rutishauser G. Are nuclear shape factors good predictors of the disease course in patients with carcinoma of the prostate? Prog Clin Biol Res 1987, 243A:533–537.
   Google Scholar
• Mohler JL, Partin AW, Epstein JI, Lohr WD, Coffey DS. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. J Urol 1988a, 139:1085–1090.
   PubMed Web of Science ®Google Scholar
• Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JI, Coffey DS. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer:a critical analysis. J Urol 1989, 142:1254–1258.
   Web of Science ®Google Scholar
• Martinez-Jabaloyas JM, Ruiz-Cerda JL, Hernandez M, Jimenez A, Jimenez-Cruz F. Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation. Urology 2002, 59 (5):715–20.
   Web of Science ®Google Scholar
• Martinez Jabaloyas JM, Jimenez Sanchez A, Ruiz Cerda JL, Sanz Chi-nesta S, Sempere A, Jimenez Cruz JF. Prognostic value of DNA ploidy and nuclear morphometry in metastatic prostate cancer. Actas Urol Esp 2004, 28 (4):298–307.
   Google Scholar
• Maffini MV, Ortega HH, Stoker C, Giardina RH, Luque EH, Munoz de Toro MM. BcI-2 correlates with tumour ploidy and nuclear morphology in early stage prostate carcinoma, fine needle aspiration biopsy study. Pathol Res Pract 2001,197 (7):487–92.
   Web of Science ®Google Scholar
• Buhmeida A, Kuopio T, Collan Y. Nuclear size and shape in fine needle aspiration biopsy samples of the prostate. Anal Quant Cytol Histol 2000, 22 (4):291–8.
   PubMedGoogle Scholar
• Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A 2004, 20; 101 (3):811–6.
   Web of Science ®Google Scholar
• Quinn DI, Henshall SM, Sutherland RL. Molecular markers of prostate cancer outcome. Eur J Cancer 2005, 41 (6):858–87.
   Web of Science ®Google Scholar